Used in cancer research and therapy development due to its specific binding to CLEC14A, a protein overexpressed in tumor blood vessels. This antibody enables targeted delivery of therapeutic agents to tumor sites and is utilized in diagnostic imaging to detect solid tumors. It also serves as a tool in studying angiogenesis and tumor microenvironment interactions. Its high specificity makes it valuable for developing monoclonal antibody-based treatments, particularly in oncology drug discovery and preclinical studies.